<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0016">
 <element-citation publication-type="journal" id="sbref0016">
  <person-group person-group-type="author">
   <name>
    <surname>Mayer</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Kappos</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Racke</surname>
    <given-names>M.K.</given-names>
   </name>
   <name>
    <surname>Rammohan</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Traboulsee</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Hauser</surname>
    <given-names>S.L.</given-names>
   </name>
   <name>
    <surname>Julian</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>KÃ¶ndgen</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Napieralski</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Zheng</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Wolinsky</surname>
    <given-names>J.S.</given-names>
   </name>
  </person-group>
  <article-title>Ocrelizumab infusion experience in patients with relapsing and primary progressive multiple sclerosis: Results from the phase 3 randomized OPERA I, OPERA II, and ORATORIO studies</article-title>
  <source>Mult. Scler. Relat. Disord.</source>
  <volume>30</volume>
  <year>2019</year>
  <fpage>236</fpage>
  <lpage>243</lpage>
  <pub-id pub-id-type="pmid">30844611</pub-id>
 </element-citation>
</ref>
